Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cancer
    • New combination...

    New combination strategy may kill cancer cells better: study

    Written by Hina Zahid Published On 2019-09-16T19:25:22+05:30  |  Updated On 16 Sept 2019 7:25 PM IST
    New combination strategy may kill cancer cells better: study

    In their bid to tackle cancer, scientists have been trying out newer and innovative strategies. In a preliminary study, Indian scientists have explored the possibility of reaching out to cancer cells and triggering their natural programmed death.


    This approach uses the combined effect of targeting and inducing a ‘stress’ inside the cell structures called Endoplasmic Reticulum of tumor cells, along with administering a small amount of a drug. Laboratory tests on cervical cancer cell lines have found that the combination treatment increases the death of cancer cells due to apoptosis or natural cell disintegration.


    Endoplasmic Reticulum is a network of folded membrane spreading across the cell. It is the protein and lipid factory of the cell, responsible for manufacturing, packaging and dispersing of various functional proteins for the body.


    The production process sometimes yields unwanted proteins, which are immediately scavenged away by another resident protein called Hsp 90. When Hsp 90 stops functioning many waste proteins build up inside the cell, creating stress, which eventually kills the cell.


    The present study focuses on inhibiting Hsp 90 in cancer cells, thereby initiating their death.


    “The key aspect of our research is to navigate inside cancer cells, reach the protein synthesis organelle and trigger stress into it for therapy. For this, we have engineered a nanoparticle which can do that as well as show us how it reaches its target, in this case, endoplasmic reticulum, inside the cancer cells,” explained Dr Sudipta Basu, the lead researcher of the study at the Indian Institute of Technology, Gandhinagar, while speaking to India Science Wire.








    To target the endoplasmic reticulum, the team synthesized a lipid-modified molecule and attached a chemical entity called sulfoxide to its structure such that it would be recognized by the external receptor structure of endoplasmic reticulum. A fluorescent chemical acted as a tracking system tag which traced the path and ascertained the destination of the nanoparticle.


    Then, an Hsp 90 inhibiting drug called 17AAG was encapsulated in the lipid nanoparticle to form a nano-package which would quickly disperse in water, which is the chief constituent of cells. The size of the nano packages was so designed to easily enter through pores of cancerous cells and at the same time, be blocked by small healthy cells. By doing so, the team hypothesized that the nano packages target tumor cells explicitly with minimal effect on healthy cells.


    When tracked by a confocal microscope, it was confirmed that nano packages reached and permeated into the endoplasmic reticulum and dispersed in the cells. A cell enzyme called Esterase broke opened the nano package to release 17AAG, which inhibited the housekeeping protein Hsp 90, leading to the build-up of unwanted proteins in the tumor cells.


    Cell and molecular biology techniques revealed that 17AAG activated stress in the ER, which led to a fair amount of cell death due to the nano packages.


    However, cancer cells are known to respond in a ‘smart’ way to the endoplasmic reticulum stress by resorting to autophagy. Autophagy is a survival mechanism of the cancer cells where they eat up their unnecessary proteins to stay alive. To overcome this, chloroquine was introduced, which is an antimalarial drug found to have autophagy inhibitor and anticancer potential. The combination treatment resulted in a significant death of cancer cells.


    “Indirect drug treatment, cancer cells get acclimatized to the drug and develop resistance toward it, while the combined strategy may offer a better scope of treatment down the line. Although our research is in the early stages, our work proves that this strategy has the potential as a safer route for cancer treatment,” said Dr. Basu. The team now proposes further studies.


    Besides Sudipta Basu, the research team included Chandramouli Ghosh and Aditi Nandi from Indian Institute of Science Education and Research (IISER), Pune. The results were published in journal ACS Applied Biomaterials


    By Susheela Srinivas


    India Science Wire









    ACS Applied BiomaterialsapoptosisBesides Sudipta Basucancer cellsDr Sudipta Basuendoplasmic reticulumGandhinagarHsp 90India Science WireIndian Institute of Science Education and ResearchIndian Institute of TechnologyLaboratory testsstresssulfoxidetackle cancertumor cells

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok